Cargando…

Differences in All-Cause Health Care Utilization and Costs in a Type 2 Diabetes Mellitus Population with and Without a History of Cardiovascular Disease

BACKGROUND: Multiple studies have reported that type 2 diabetes mellitus (T2DM) is a major risk factor for cardiovascular diseases (CVD), and presence of T2DM and CVD increases risk of death. There is growing interest in examining the effects of antidiabetic treatments on the reduction of cardiovasc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mehta, Sandhya, Ghosh, Sabyasachi, Sander, Stephen, Kuti, Effie, Mountford, William K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397852/ https://www.ncbi.nlm.nih.gov/pubmed/29485954 http://dx.doi.org/10.18553/jmcp.2018.24.3.280

Ejemplares similares

Glycated Hemoglobin Predicts All-Cause, Cardiovascular, and Cancer Mortality in People Without a History of Diabetes Undergoing Coronary Angiography
por: Silbernagel, Guenther, et al.
Publicado: (2011)

Low Insulin Is an Independent Predictor of All‐Cause and Cardiovascular Death in Acute Decompensated Heart Failure Patients Without Diabetes Mellitus
por: Nogi, Maki, et al.
Publicado: (2020)

Diabetes Mellitus–Related All‐Cause and Cardiovascular Mortality in a National Cohort of Adults
por: Raghavan, Sridharan, et al.
Publicado: (2019)

Hospital Admissions, Costs, and 30-Day Readmissions Among Newly Diagnosed Nonvalvular Atrial Fibrillation Patients Treated with Dabigatran Etexilate or Warfarin
por: Fonseca, Eileen, et al.
Publicado: (2015)

Comparative Analysis of All-Cause Health Care Resource Utilization and Costs Among Venous Thrombosis Patients Without Cancer Prescribed Apixaban or VKAs in France
por: Mokgokong, Ruth, et al.
Publicado: (2022)

Administrative Claims Analysis of All-Cause Annual Costs of Care and Resource Utilization by Age Category for Ulcerative Colitis Patients
por: Bickston, Stephen J., et al.
Publicado: (2008)

Psychological Distress and All-Cause, Cardiovascular Disease, Cancer Mortality Among Adults with and without Diabetes
por: Huang, Wentao, et al.
Publicado: (2021)

Sex Differences in Cardiovascular and All-Cause Mortality in Adults with and without CKD: NHANES 1999–2018
por: Oh, Ester S., et al.
Publicado: (2023)

Impacts of Pre-Diabetes or Prehypertension on Subsequent Occurrence of Cardiovascular and All-Cause Mortality among Population without Cardiovascular Diseases
por: Huang, Yu-qing, et al.
Publicado: (2020)

Cost–utility analysis of liraglutide compared with sulphonylurea or sitagliptin, all as add-on to metformin monotherapy in Type 2 diabetes mellitus
por: Davies, M J, et al.
Publicado: (2012)

All-Cause Health Care Utilization and Costs Associated with Newly Diagnosed Multiple Sclerosis in the United States
por: Asche, Carl V., et al.
Publicado: (2010)

Target Values of Cardiovascular Risk Factors Are Not Associated with All-Cause Mortality in Patients with Type 2 Diabetes Mellitus
por: Pacilli, Antonio, et al.
Publicado: (2015)

Physical Activity and the Development of Post-Transplant Diabetes Mellitus, and Cardiovascular- and All-Cause Mortality in Renal Transplant Recipients
por: Byambasukh, Oyuntugs, et al.
Publicado: (2020)

Impact of preexisting diabetes mellitus on cardiovascular and all-cause mortality in patients with atrial fibrillation: A meta-analysis
por: Xu, Juan, et al.
Publicado: (2022)

Arm Circumference, Arm-to-Waist Ratio in Relation to Cardiovascular and All-Cause Mortality among Patients with Diabetes Mellitus
por: Xiao, Xinyu, et al.
Publicado: (2023)

Impact of Annual Cardiovascular Screening Tests in Patients with Type 2 Diabetes Mellitus without Previous Histories of Cardiovascular Disease: Four-year Clinical Outcomes
por: Antoku, Yoshibumi, et al.
Publicado: (2021)

The Adiponectin Paradox for All-Cause and Cardiovascular Mortality
por: Menzaghi, Claudia, et al.
Publicado: (2018)

All-cause mortality and cardiovascular events in a Spanish nonagenarian cohort according to type 2 diabetes mellitus status and established cardiovascular disease
por: Salinero-Fort, MA, et al.
Publicado: (2022)

U-Shaped Relationship of Non-HDL Cholesterol With All-Cause and Cardiovascular Mortality in Men Without Statin Therapy
por: Zeng, Rui-Xiang, et al.
Publicado: (2022)

Utility of B-Type Natriuretic Peptide for Predicting Perioperative Cardiovascular Events in Patients Without History of Cardiovascular Disease Undergoing Major Non-Cardiac Surgery
por: Kim, Sung Eun, et al.
Publicado: (2011)

IT'S ALL IN THE HISTORY
por: Novotny, Julius J.
Publicado: (1993)

Early cardiovascular events in women with a history of gestational diabetes mellitus
por: Goueslard, Karine, et al.
Publicado: (2016)

Using alternatives to the car and risk of all-cause, cardiovascular and cancer mortality
por: Panter, Jenna, et al.
Publicado: (2018)

Analysis of National Health and Insurance Registers for All-Cause Mortality in Patients with Heart Failure with and without Diabetes Mellitus in Poland in 2012
por: Wierzba, Waldemar, et al.
Publicado: (2019)

History of Gestational Diabetes Mellitus in Relation to Cardiovascular Disease and Cardiovascular Risk Factors in US Women
por: Shostrom, Derrick C. V., et al.
Publicado: (2017)

Empagliflozin in Type 2 Diabetes Mellitus Patients with High Cardiovascular Risk: A Model-Based Cost-Utility Analysis in China
por: Men, Peng, et al.
Publicado: (2020)

Cardiovascular complications in COVID‐19 patients with or without diabetes mellitus
por: Abe, Temidayo, et al.
Publicado: (2020)

Legume Consumption and All-Cause and Cardiovascular Disease Mortality
por: Li, Hua, et al.
Publicado: (2017)

Cost-utility of Protocols of BFM-ALL and UK-ALL for Treatment of Children with Acute Lymphoblastic Leukemia in Iran
por: HAYATI, Hadi, et al.
Publicado: (2018)

Sex Differences in All-Cause and Cardiovascular Mortality, Hospitalization for Individuals With and Without Diabetes, and Patients With Diabetes Diagnosed Early and Late
por: Roche, Madonna M., et al.
Publicado: (2013)

Association between ankle-brachial blood pressure index with all-cause and cardiovascular mortality in adults without arterial stiffness
por: Meng, Zhe, et al.
Publicado: (2023)

The relationship between N-terminal prosomatostatin, all-cause and cardiovascular mortality in patients with type 2 diabetes mellitus (ZODIAC-35)
por: van Dijk, Peter R, et al.
Publicado: (2015)

Nodular glomerulosclerosis in patients’ without history of diabetes mellitus: a case report
por: Helal, Imed, et al.
Publicado: (2009)

Is ischemia the only factor predicting cardiovascular outcomes in all diabetes mellitus patients?
por: Kennedy, Mark W., et al.
Publicado: (2017)

Endothelial Dysfunction and Cardiovascular Disease: History and Analysis of the Clinical Utility of the Relationship
por: Little, Peter J., et al.
Publicado: (2021)

Impact of atherosclerotic cardiovascular disease on healthcare resource utilization and costs in patients with type 2 diabetes mellitus in a real-world setting
por: Weng, Wayne, et al.
Publicado: (2020)

Differential predictive factors for cardiovascular events in patients with or without cancer history
por: Sueta, Daisuke, et al.
Publicado: (2019)

Using Published Health Utilities in Cost-Utility Analyses: Discrepancies and Issues in Cardiovascular Disease
por: Zhou, Ting, et al.
Publicado: (2021)

Impact of diabetes mellitus on risk of cardiovascular disease and all-cause mortality: Evidence on health outcomes and antidiabetic treatment in United States adults
por: Liu, Longjian, et al.
Publicado: (2016)

Association Between Diabetes Mellitus and All-Cause and Cardiovascular Mortality Among Individuals With Ultrasound-Defined Non-Alcoholic Fatty Liver Disease
por: Wu, Weiti, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cs2ajuj75ir0lrdtnd9jiidig3